ArticleCell death discovery2021

HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma.

Tian Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.